ARTINI, PAOLO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 12.268
AS - Asia 5.948
EU - Europa 3.579
SA - Sud America 806
AF - Africa 136
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.757
Nazione #
US - Stati Uniti d'America 11.959
SG - Singapore 1.804
CN - Cina 1.726
HK - Hong Kong 1.089
IT - Italia 946
BR - Brasile 657
SE - Svezia 574
VN - Vietnam 516
BG - Bulgaria 423
DE - Germania 397
CA - Canada 242
TR - Turchia 241
FI - Finlandia 212
FR - Francia 204
RU - Federazione Russa 199
GB - Regno Unito 193
UA - Ucraina 192
KR - Corea 188
IN - India 84
JP - Giappone 69
CH - Svizzera 67
AR - Argentina 60
BD - Bangladesh 44
MX - Messico 33
ZA - Sudafrica 32
IE - Irlanda 31
CI - Costa d'Avorio 28
BE - Belgio 27
IQ - Iraq 26
NL - Olanda 25
PK - Pakistan 24
CL - Cile 22
ID - Indonesia 22
EC - Ecuador 19
PL - Polonia 19
ES - Italia 18
MA - Marocco 16
SA - Arabia Saudita 16
VE - Venezuela 14
KE - Kenya 13
CO - Colombia 12
AT - Austria 11
AU - Australia 11
UZ - Uzbekistan 11
IR - Iran 10
SN - Senegal 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
PE - Perù 9
JO - Giordania 8
MY - Malesia 8
UY - Uruguay 8
EG - Egitto 7
PH - Filippine 7
BB - Barbados 6
DZ - Algeria 6
NP - Nepal 6
TW - Taiwan 6
AL - Albania 5
CR - Costa Rica 5
LT - Lituania 5
NG - Nigeria 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
BJ - Benin 4
IL - Israele 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TN - Tunisia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
OM - Oman 3
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HU - Ungheria 2
NO - Norvegia 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TG - Togo 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CM - Camerun 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
IS - Islanda 1
KW - Kuwait 1
Totale 22.738
Città #
Ashburn 1.141
Woodbridge 1.103
Hong Kong 1.078
Fairfield 1.007
Singapore 998
Dallas 916
Ann Arbor 748
Houston 693
Chandler 663
Santa Clara 612
San Jose 580
Sofia 419
Seattle 387
Shanghai 354
Wilmington 349
Beijing 342
Cambridge 336
Milan 314
New York 280
Jacksonville 243
Hefei 216
Boardman 208
Ottawa 196
Los Angeles 195
Seoul 179
Princeton 169
Lawrence 164
Lauterbourg 151
Medford 151
Izmir 148
Council Bluffs 143
Nanjing 142
Frankfurt am Main 136
Ho Chi Minh City 129
Des Moines 109
Dong Ket 82
Buffalo 80
Istanbul 73
Hanoi 69
Bern 64
Columbus 63
Tokyo 63
Dearborn 62
Nanchang 62
The Dalles 55
Redondo Beach 52
Helsinki 51
São Paulo 50
San Diego 43
Munich 42
Jüchen 40
Florence 38
Redwood City 38
Rome 38
Ogden 33
Boulder 32
Dublin 32
Lancaster 31
Serra 31
Abidjan 28
Kunming 28
Falls Church 26
Hebei 26
Shenyang 26
Tianjin 25
Brussels 23
Changsha 23
Rio de Janeiro 22
Belo Horizonte 21
Chicago 21
Hangzhou 20
Da Nang 19
Pisa 19
Montreal 18
London 17
Guangzhou 16
Jiaxing 16
Fuzhou 15
Paris 15
Pune 15
San Francisco 15
Campinas 14
Chennai 14
Haiphong 14
Jinan 14
Johannesburg 14
Orem 14
Phoenix 14
Warsaw 14
Brasília 13
Nairobi 13
Norwalk 13
Parabiago 13
Baghdad 12
Brooklyn 12
Nuremberg 12
Stockholm 12
Turku 12
Wuhan 12
Atlanta 11
Totale 16.924
Nome #
PCOS and Assisted Reproduction Technique: Role and Relevance of Inositols 563
Premature ovarian insufficiency: current progress and future prospectives 225
Cellular and molecular aspects of ovarian follicle ageing 222
Doppler analysis in pregnancies complicated by pregnancy-induced hypertension and fetal growth retardation 203
Endometrial dysbiosis is related to inflammatory factors in women with repeated implantation failure: a pilot study 196
Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients 196
Ultrasonographic and color doppler analysis in the treatment of polycystic ovary syndrome 192
Ultrasonographic patterns of polycystic ovaries:color doppler and hormonal correlations 184
Assisted reproductive technique in women of advanced fertility age 184
Color Doppler analysis in lean and obese women with polycystic ovary syndrome 183
Inositol and in vitro fertilization with embryo transfer 182
The natural carotenoid crocetin and the synthetic tellurium compound as101 protect the ovary against cyclophosphamide by modulating sirt1 and mitochondrial markers 182
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise 181
Brain-derived neurotrophic factor in plasma of women with endometriosis 179
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 178
Growth hormone cotreatment with gonadotropins in ovulation induction 178
From the diagnosis of sterility/infertility to the protocols of assisted reproduction: Psychological aspects of sterile couples [Dalla diagnosi di sterilità/infertilità ai protocolli di procreazione assistita: Vissuti psicologici delle coppie sterili] 178
Amélioration de la résponse ovarienne à l'induction de l'ovulation par un traitement associant l'hormone de croissance et les gonadotrophines ou la LHRH pulsatile:ròle éventuel des facteurs de croissance ovarienne 174
FEMALE REPRODUCTIVE DYSFUNCTION DURING AGEING: ROLE OF METHYLGLYOXAL IN THE FORMATION OF ADVANCED GLYCATION AND PRODUCTS IN OVARIES OF REPRODUCTIVELY-AGED MICE 173
Peroxisome proliferator-activated receptors in female reproduction and fertility 172
Follicular fluid lipoproteins in preovulatory period and their relationship with follicular maturation and progesterone production by human granulosa-luteal cells in vivo and in vitro 170
Corticotropin-Releasing Factor-Binding Protein:Origins and Possible Functions 167
Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes 167
MicroRNAs are stored in human MII oocyte and their expression profile changes in reproductive aging 167
Comparison between GnRH agonist and antagonist protocols for severe endometriosis in assisted reproductive cycles 166
Human Breast Milk: Exploring the Linking Ring Among Emerging Components 166
Frontiers in gynecological endocrinology: volume 2: from basic to clinical application 165
Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis 165
Biologia e tecnologie della riproduzione umana 164
Exploring Epithelial-Mesenchymal Transition Signals in Endometriosis Diagnosis and In Vitro Fertilization Outcomes 164
Preovulatory human follicular fluid in vitro inhibits interleukin(IL)-1alfa,IL-2,and production and expression of p55 chain IL-2 receptor of lymphomonocytes 163
Best Methods for identification and treatment of PCOS 163
Absent or reversed end-diastolic flow in umbilical artery and severe intrauterine growth retardation 162
Color doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 162
Insulin-like growth factor-1 (igf-1) and igf-1 binding protein in the follicular fluids of growth hormone treated patients 160
Vascular endothelial growth factor and its soluble receptor in ovarian pathology 158
PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome 158
DHEA supplementation improves follicular microenviroment in poor responder patients 157
Regular exercise delays microvascular endothelial dysfunction by regulating antioxidant capacity and cellular metabolism 156
Liquid nitrogen snap frozen saphenous vein for vascular access in dialysis 155
Colour doppler changes and thromboxane production after ovarian stimulation with gonadotrophin-realising hormone agonist 155
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model 155
Sperm retrieval for direct intraperitoneal insemination in a diabetic with retrograde ejaculation 152
Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre. 152
Thyroid peroxidase identified in human granulosa cells: another piece to the thyroid-ovary puzzle? 152
L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study. 151
In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization 151
Oxidative Stress-Related Signaling Pathways Predict Oocytes’ Fertilization In Vitro and Embryo Quality 150
Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome 148
Current issues in assisted reproductive technology [Attualità in tema di procreazione medicalmente assistita] 147
Activin beta a subunit is expressed in bovine oviduct 146
Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: A noninferiority randomized controlled study 146
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata 145
Doppler analysis of uterine blood flow changes in spontaneous and medically induced menopause 145
Gene expression in cumulus cells and oocyte quality 145
Membrane integrity evaluation in rabbit spermatozoa 143
Coenzyme Q10 levels in human follicular fluid 142
Cord vessel compression by an expanding allantoic cyst: case report. 142
Endometriosis and oocyte quality: the role of ROS 142
Uterine and ovarian blood flow measurement.Does the full bladder modify the flow resistance? 141
Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity. 140
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology 140
A comparative,randomized study of three different progesterone support of the luteal phase following IVF/ET program 140
Inside the granulosa transcriptome 139
Pregnancy following regression of uterine submucosal leiomyoma with GnRH therapy;a case report 138
The role of robotics in the management of endometriosis 138
Brain derived neurotrophic factor circulating levels in patients undergoing IVF 138
Hemodynamic,hematological and hemorrheological evaluation of post-term pregnancy 137
Comparison of reproductive outcomes using IVF-ET and ICSI in ART cycles in which only one or two oocytes are retrieved 137
Embryo development using fresh and vitrified oocytes 136
Evidence that granulosa cells inhibit interleukin-1alfa and interleukin-2 production from follicular lymphomonocytes 135
Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization 135
Effects of reproductive aging and postovulatory aging on the maintenance of biological competence after oocyte vitrification: Insights from the mouse model 134
Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects 134
Breakthroughs in the human embryology laboratory... what are the real triggers? 131
Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome. 130
Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients 129
Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program 129
Relationship between human oocyte maturity, fertilization and follicular fluid growth factors 129
Magnesium pyrrolidine in threatening preterm labor. Doppler analysis of the effects on various regions of the fetal vascular system | [IL MAGNESIO PIRROLIDONE NELLE MINACCE DI PARTO PRETERMINE. VALUTAZIONE DOPPLER DEGLI EFFETTI INDOTTI SU DIVERSI DISTRETTI VASCOLARI DEL FETO] 128
Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: A pilot study 127
Respiratory Mitochondrial Efficiency and DNA Oxidation in Human Sperm after In Vitro Myo-Inositol Treatment 127
Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation 126
Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation 126
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study* 126
Cryopreservation and ossidative stress in reproductive cells 125
Ovarian follicular fluid contains immunoreactive estriol:lack of correlation with estradiol concentrations 125
Color Doppler hysterosalpingography in the diagnosis of tubal patency 123
Acyl-Carnitines Exert Positive Effects on Mitochondrial Activity under Oxidative Stress in Mouse Oocytes: A Potential Mechanism Underlying Carnitine Efficacy on PCOS 122
Pregnancy following combined growth hormone-pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea 122
Carnitines as Mitochondrial Modulators of Oocyte and Embryo Bioenergetics 122
Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells 121
Ovary and senium 120
THE ROLE OF COLOR DOPPLER IMAGING IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME 120
Biomarkers of ovarian ageing 120
Difficult-to-treat women for controlled ovarian hyperstimulation: Tips and tricks 119
Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy. 119
Molecular Research on Polycystic Ovary Syndrome (PCOS) 118
Regulatory functions of L-carnitine, acetyl and propionyl L-carnitine in a PCOS mouse model: focus on antioxidant/antiglycative molecular pathways in the ovarian microenvironment 118
Impact of Italian legislation regulating assisted reproduction techniques on ICSI outcomes in severe male factor infertility: a multicentric survey 117
Totale 15.470
Categoria #
all - tutte 63.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.629 17 65 25 89 363 261 27 70 144 32 65 471
2022/20231.805 247 204 110 186 191 224 26 127 359 13 99 19
2023/20241.445 178 149 193 95 195 316 68 34 30 6 42 139
2024/20254.896 21 193 50 294 431 481 436 313 511 719 511 936
2025/20265.538 247 737 1.097 467 421 479 899 216 303 388 161 123
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 22.957